3rd Circ. Says Pa. Fen-Phen Suit Barred By Earlier MDL Deal

Law360, New York (January 28, 2013, 7:30 PM EST) -- The Third Circuit on Monday defeated a Pennsylvania couple’s fen-phen product liability suit against Wyeth Pharmaceuticals Inc. and Pfizer Inc., saying in a precedential opinion that their claims are barred by the 1999 settlement covering multidistrict litigation over the diet drugs’ health risks.

A three-judge panel ruled that a Pennsylvania federal court got it right when it enjoined plaintiffs Carmen Cauthen and Ricky Leon Cauthen’s suit, saying they did not qualify for a cause of action exemption that would have allowed them to proceed with the...
To view the full article, register now.